Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM

Autor: R. M. Wilson, Gordon W. Duff, C M Artlett, J. D. Ward, Anthony G. Wilson, A M Gonzalez, Ken I. Welsh, Angela Cox

Publikováno v: Diabetologia. 37:500-503

Insulin-dependent diabetes mellitus (IDDM) is associated with class II molecules of the MHC on chromosome 6, in particular HLA-DR and -DQ al-leles, but a pathogenic role for TNF-a in the class III region of the MHC has also been implied. We therefore

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a5136628ff38c007d14ccfc8cbc621
https://doi.org/10.1007/s001250050138

Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis

Autor: E G, Hitraya, J, Varga, C M, Artlett, S A, Jiménez

Publikováno v: Arthritis and rheumatism. 41(11)

To identify regulatory elements in the promoter region of the alpha1(I) procollagen gene (COL1A1) involved in the transcriptional activation of this gene in systemic sclerosis (SSc), and to identify the transcription factors interacting with these re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aa23d72cf97c3fc2496309c27c9b9ca9
https://pubmed.ncbi.nlm.nih.gov/9811061

HLA class III associations in pemphigoid (herpes) gestationis

Autor: Kenneth I. Welsh, Martin M. Black, C. M. Artlett, J.F. Shornick, Balbir S. Bhogal, R.E. Jenkins

Publikováno v: Journal of Dermatological Science. 6:107

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c167dc5384c9e07ee032e2c7a1bee55
https://doi.org/10.1016/0923-1811(93)91336-s

Artificial keloid skin models: understanding the pathophysiological mechanisms and application in therapeutic studies.

Autor: Kwon, Soo hyun, Lee, Jongmin, Yoo, Jin, Jung, Youngmee

Publikováno v: Biomaterials Science (2047-4830); 7/7/2024, Vol. 12 Issue 13, p3321-3334, 14p

Foetal Microchimerism Correlates With Foetal-Maternal Histocompatibility Both During Pregnancy and Postpartum.

Autor: Staff AC; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Fjeldstad HE; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Olsen MB; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway., Øgaard J; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Norwegian PSC Research Center, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Viken MK; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway.; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway., Kramer CSM; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Eikmans M; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Kroneis T; Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria., Sallinger K; Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria., Kanaan SB; Chimerocyte, Inc., Seattle, Washington, USA., Sugulle M; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Jacobsen DP; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Publikováno v: HLA [HLA] 2024 Oct; Vol. 104 (4), pp. e15717.